Analyst Ratings for NxStage Medical (NXTM)

NXTM Rating Summary

NXTM Price Target Summary

* Over Last 12-Mos
  |   Expand Research on NXTM
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $24.25 (+9.7%) * Over Last 12-Mos
Rating Score: 6.9 / 10   Percentile Rank: 77%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
6/28/2016 Northland Capital Markets Upgrade Outperform
(Market Perform)
25.00
(N/A)
19.46 22.11 13.62% Details
3/31/2016 Piper Jaffray
» Updated 6/8/2016
New Coverage Overweight
(N/A)
21.00
(N/A)
14.96 22.11 47.79% Details
Like NXTM Ratings? Also take a look at FMS, BAX

NXTM Ratings News